Genghis Lloyd-Harris

Investing Profile

Sweet spot: $22.5M Range: $15M–$30M Fund: $465M

About Genghis Lloyd-Harris

We are an international investment group that partners with entrepreneurs in the industry.

Abingworth thesis

About Team Strategy Portfolio Media Contact Investors Portfolio What drives our investments is the prospect of new treatments that will materially improve patients’ lives. That word “materially” is important: we are looking for game-changers and paradigm-shifts, not just incremental improvements. Browse our portfolio to see what this means in practice. For media enquires please email abingworth@medistrava.com or call +44 (0)20 3926 8535 © Abingworth LLP 2026 | Site by Ether Legal Privacy Policy Cookie Policy Terms & Conditions Contact info@abingworth.com +44 (0)20 7534 1500 1 St James's Market

Sector and stage focus

  • Series B: BioTech, Medical Devices, Pharmaceuticals, Health & Hospital Services, Diagnostics, Health IT
  • Series A: Medical Devices, Pharmaceuticals, BioTech, Health IT, Health & Hospital Services, Diagnostics
  • general: London

Is Genghis Lloyd-Harris a fit for your round?

Upload your pitch deck and see whether Genghis Lloyd-Harris appears in your top 20 matches.

Find investors for your deck